Identifying Missing Opportunities in the CDI Process through Iodine Software’s Retrospect Application

 

Technology adoption in healthcare is progressing rapidly, and the domain of Clinical Documentation Integrity (CDI) is no exception. Physicians want simplified EHRs and easy-to-use CDIs. When used correctly and efficiently, CDI can positively impact care. A critical tool in this evolution is Iodine Software’s Retrospect Application, a part of its AwareCDI Suite, which facilitates the review of healthcare encounters and ensures no vital information is overlooked. As the healthcare sector evolves to meet the demands of a digitized world, tools like Retrospect are essential in improving efficiency and accuracy.

What makes Iodine Software’s Retrospect Application a powerful tool for CDI specialists? How does it contribute to the meticulous review process and ensure no information falls through the cracks?

Iodine Software customer Sheila Duhon, Director of Clinical Documentation Integrity at Steward Healthcare, provided Iodine Intelligence with her thoughts on Iodine Software’s Retrospect Application and its impact on Steward Healthcare’s CDI process.

Highlights covered:

  • The function of the Retrospect Application in reviewing healthcare encounters and identifying any missed opportunities in CDI or coding
  • The role of the Retrospect Application in monitoring Hospital Acquired Conditions (HACs) and Patient Safety Indicators (PSIs)
  • The swift and successful implementation of the Retrospect Application at Steward Healthcare

Sheila Duhon, a seasoned healthcare professional, is the Director of Clinical Documentation Integrity at Steward Healthcare, one of the largest private, physician-led healthcare networks in the United States. Duhon is known for her customer-centric approach. Under her leadership, Steward Healthcare partnered with Iodine Software to develop and implement solutions like Forecast, further solidifying its commitment to technological innovation in healthcare.

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…